D-0170-2017 Class III Terminated
FDA drug recall D-0170-2017 was initiated by Teva Pharmaceuticals USA on Nov 1, 2016 and is designated Class III. Reason for recall: Failed Content Uniformity: Product was out of specification for spray content uniformity obtained during stability testing. The recall status is terminated (terminated Feb 6, 2018). Affected quantity: 201, 234 Canisters.
Recall details
- Product Type
- Drugs
- Report Date
- Dec 14, 2016
- Initiation Date
- Nov 1, 2016
- Termination Date
- Feb 6, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 201, 234 Canisters
Product description
Qnasl (beclomethasone dipropionate) Nasal Aerosol 40 Mcg, 60 Metered Sprays, Rx only, Manufactured for Teva Respiratory, LLC, Horsham, PA 19044, By: 3M Drug Delivery Systems, Northridge, CA 91324, NDC 59310-206-06 and 59310-206-08 (Physician Samples).
Reason for recall
Failed Content Uniformity: Product was out of specification for spray content uniformity obtained during stability testing.
Distribution pattern
Nationwide
Code information
Lot #: 150096, Exp. 3/2017; Lot #: 150327, Exp. 10/2017
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0170-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026